Glaxo signs drug-development deal with British firm - Philadelphia Inquirer

stv.tv

Glaxo signs drug-development deal with British firm Philadelphia Inquirer, PA By Miriam Hill GlaxoSmithKline PLC signed a deal yesterday to develop drugs to treat rheumatoid arthritis and other inflammatory diseases. The agreement to work with Chroma Therapeutics Ltd. of Oxford, England, to develop new products represents ... GlaxoSmithKline Signs Research Deal With Chroma Therapeutics Wall Street Journal GlaxoSmithKline unites on arthritis drug Hays Pharma GSK signs drug pact with Chroma Therapeutics domain-B Forbes - Reuters all 41 news articles

MorphoSys files for Phase 1b/2a trial for MOR103 in rheumatoid ... - Trading Markets (press release)

MorphoSys files for Phase 1b/2a trial for MOR103 in rheumatoid ... Trading Markets (press release), CA ... Biotechnology company MorphoSys AG (FSE: MOR) has submitted an application for the authorisation of a phase 1b/2a clinical study in patients with active rheumatoid arthritis (RA) for its lead drug MOR103, the company announced on Wednesday. ... MorphoSys Reports Filing for Phase 1b/2a Trial for its Lead ... MarketWatch MorphoSys Reports Filing for Phase 1b/2a Trial for its Lead ... PR-Inside.com (Pressemitteilung) all 20 news articles

New rheumatoid arthritis drug is promising - United Press International

New rheumatoid arthritis drug is promising United Press International PARIS, June 22 (UPI) -- A French study shows the drug masitinib, being developed for the treatment of rheumatoid arthritis, appears to be well tolerated and effective, researchers say. The clinical trial, led by Olivier Hermine of Necker Hospital in ... Masitinib in the treatment of active rheumatoid arthritis: results ... 7thSpace Interactive (press release) all 7 news articles

New Educational Initiative Urges People with Rheumatoid Arthritis ... - PR Newswire (press release)

New Educational Initiative Urges People with Rheumatoid Arthritis ... PR Newswire (press release), NY Wyeth Europa, Maidenhead, UK - Tuesday 23rd June 2009: /PRNewswire/ — Recognising that rheumatoid arthritis (RA) can cause deformity, disability and loss of independence without effective management – My Day for RA, a new educational programme, ... New Educational Initiative Urges People With Rheumatoid Arthritis ... Merinews all 7 news articles